Forsyth Institute

NEW YORK (GenomeWeb News) – The Forsyth Institute plans to use a $4.1 million grant from the Massachusetts Life Sciences Center (MLSC) to create a new center that will develop saliva-based molecular diagnostic tests for assessing disease risk.

This article has been updated to clarify that the Forsyth Institute was the recipient of the Gates Foundation grant.
By a GenomeWeb staff reporter

Scientists at Forsyth will focus on discovering biomarkers in saliva that may indicate metabolic disease and the development of diabetes.

A team of researchers based in Germany and China used 16S rRNA sequencing to begin cataloguing the bacterial genera in saliva samples from 120 people around the world in search of informative bugs.

The US Food and Drug Administration has approved Alnylam's RNAi-based therapy Onpattro, according to Stat News.

Harvard Medical School's Seth Cassel and Cigall Kadoch argue in a Baltimore Sun op-ed that the recent TAILORx trial shows the potential of genomic-based medicine.

Researchers in the UK are working on using gene drives to control malaria-carrying mosquitoes, the Telegraph reports.

In PLOS this week: genetic architecture mediating gene expression, metabolomic patterns in multiple myeloma, and more.